Torrent Pharmaceuticals gets EIR for Gujarat Oral-Oncology manufacturing facility

16 Jun 2023 Evaluate

Torrent Pharmaceuticals has received Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for Oral-Oncology manufacturing facility at Bileshwarpura, Gujarat. The inspection has now been successfully closed by the USFDA. Earlier, USFDA had conducted inspection at the said manufacturing facility from March 13, 2023 to March 17, 2023.

Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3988.00 13.10 (0.33%)
21-Jan-2026 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.45
Dr. Reddys Lab 1173.75
Cipla 1379.00
Zydus Lifesciences 882.60
Lupin 2180.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×